Annual Cash & Cash Equivalents
$148.21 M
+$66.19 M+80.70%
December 31, 2023
Summary
- As of February 7, 2025, NGNE annual cash & cash equivalents is $148.21 million, with the most recent change of +$66.19 million (+80.70%) on December 31, 2023.
- During the last 3 years, NGNE annual cash & cash equivalents has risen by +$77.67 million (+110.10%).
- NGNE annual cash & cash equivalents is now at all-time high.
Performance
NGNE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$66.63 M
-$44.40 M-39.99%
September 30, 2024
Summary
- As of February 7, 2025, NGNE quarterly cash and cash equivalents is $66.63 million, with the most recent change of -$44.40 million (-39.99%) on September 30, 2024.
- Over the past year, NGNE quarterly cash and cash equivalents has increased by +$21.07 million (+46.24%).
- NGNE quarterly cash and cash equivalents is now -55.62% below its all-time high of $150.14 million, reached on March 31, 2024.
Performance
NGNE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NGNE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +80.7% | +46.2% |
| 3 y3 years | +110.1% | - |
| 5 y5 years | +110.1% | - |
NGNE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.1% | -55.6% | +46.2% |
| 5 y | 5-year | at high | +110.1% | -55.6% | +46.2% |
| alltime | all time | at high | +110.1% | -55.6% | +46.2% |
Neurogene Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $66.63 M(-40.0%) |
| Jun 2024 | - | $111.03 M(-26.0%) |
| Mar 2024 | - | $150.14 M(+1.3%) |
| Dec 2023 | $148.21 M | $148.21 M(+225.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $45.56 M(-22.8%) |
| Jun 2023 | - | $59.05 M |
| Dec 2022 | $82.02 M(+16.3%) | - |
| Dec 2021 | $70.54 M | - |
FAQ
- What is Neurogene annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Neurogene?
- What is Neurogene annual cash & cash equivalents year-on-year change?
- What is Neurogene quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Neurogene?
- What is Neurogene quarterly cash and cash equivalents year-on-year change?
What is Neurogene annual cash & cash equivalents?
The current annual cash & cash equivalents of NGNE is $148.21 M
What is the all time high annual cash & cash equivalents for Neurogene?
Neurogene all-time high annual cash & cash equivalents is $148.21 M
What is Neurogene annual cash & cash equivalents year-on-year change?
Over the past year, NGNE annual cash & cash equivalents has changed by +$66.19 M (+80.70%)
What is Neurogene quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NGNE is $66.63 M
What is the all time high quarterly cash and cash equivalents for Neurogene?
Neurogene all-time high quarterly cash and cash equivalents is $150.14 M
What is Neurogene quarterly cash and cash equivalents year-on-year change?
Over the past year, NGNE quarterly cash and cash equivalents has changed by +$21.07 M (+46.24%)